Skip to content Skip to footer
Subscribe Now
PharmaShots Interview In Conversation with ViiV Healthcare's Sr. VP, Kimberly Smith, Where she Shares Insights on the US FDA Approval for Label Update of its Lead Candidate in HIV
VIEWPOINTS

PharmaShots Interview: In Conversation with ViiV Healthcare’s Sr. VP, Kimberly Smith, Where she Shares Insights on the US FDA Approval for Label Update of its Lead Candidate in HIV

Shots: Kimberly talked about the approval for label update of ViiV’s lead candidate in HIV, and how an optional oral lead-in will be efficient for people receiving it Kimberly also spoke about ViiV’s collaboration with Janssen for the commercialization of the product  The interview gives an understanding of the different treatment options for HIV and…
June 29, 2022

Read more

PharmaShots Interview Zai Lab’s Jonathan Wang Shares Insights on KarXT (xanomeline-trospium) for the Treatment of Schizophrenia And Psychosis
VIEWPOINTS

PharmaShots Interview: Zai Lab’s Jonathan Wang Shares Insights on KarXT (xanomeline-trospium) for the Treatment of Schizophrenia And Psychosis

In an interview with PharmaShots, Jonathan Wang, Executive Vice President and Head of Business Development at Zai Lab shares his views on the license agreement with Karuna Therapeutics for KarXT (xanomeline-trospium) to treat schizophrenia and psychosis Shots: The companies collaborate to develop, manufacture & commercialize KarXT in Greater China including mainland China, Hong Kong, Macau & Taiwan Zai Lab gets exclusive rights to develop &…
February 28, 2022

Read more

Viewpoints_Kevin Cammack
VIEWPOINTS

PharmaShots Interview: Eli Lilly’s Kevin Cammack Shares Insights on Lilly’s Collaboration with Global Diabetes Technology Companies

In an interview with PharmaShots, Kevin Cammack, Head of Connected Care, Eli Lilly and Company shares insights on the Lilly alliance with DexCom, Glooko, myDiabby Healthcare, and Roche to provide compatibility between their unique digital management platforms and Lilly's Tempo Pen and Tempo Smart Button. Shots: Eli Lilly collaborates with DexCom, Glooko, myDiabby Healthcare, and Roche to…
June 28, 2021

Read more

Viewpoints_Marie Schiller
VIEWPOINTS

PharmaShots Interview: Eli Lilly’s Marie Schiller Shares Insight on the Collaboration with Welldoc on New Version of BlueStar App

In an interview with PharmaShots, Marie Schiller Vice President of Product Development for Connected Care and Insulins at Lilly shared her views on its collaboration with Welldoc to integrate Welldoc's insulin management technology into Lilly's connected insulin solutions. Shots: Lilly and Welldoc are teaming up to create a new version of Welldoc's BlueStar app which will be integrated…
April 5, 2021

Read more

Viewpoints_John Valliant
VIEWPOINTS

PharmaShots Interview: Fusion Pharma’s John Valliant Shares Insight on its Collaboration with AstraZeneca

In an interview with PharmaShots, John Valliant, CEO at Fusion Pharma shared his views on the company's agreement with AstraZeneca, signed in Nov 2020. He also shared in-depth information about the company's TATs platform & Fast-Clear linker technology and provide a glance at Fusion's portfolio. Shots:  Fusion to receive $5M up front and $40M as milestones & other payments. The…
March 24, 2021

Read more

Viewpoints_Dr. Sophia Randolph
VIEWPOINTS

PharmaShots Interview: ALX Oncology’s Dr. Sophia Randolph Shares Insight on the Clinical Collaboration with Zymework

In an interview with PharmaShot, Dr. Sophia Randolph, Chief Medical Officer of ALX Oncology shared her views on the ALX Oncology's collaboration with Zymework for evaluating the combination with ALX148 and zanidatamab for patients with advanced HER2-expressing breast cancer and other HER2-expressing solid tumors. Shots: Zymeworks will conduct a P-Ib study to assess the safety and efficacy of the combination…
February 22, 2021

Read more